1Life Healthcare Inc. (ONEM)
NASDAQ: ONEM
· Real-Time Price · USD
16.47
0.00 (0.00%)
At close: Feb 21, 2023, 10:00 PM
1Life Healthcare Revenue Breakdown
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capitated Medicare Revenue Revenue | 133.43M | 130.81M | 128.52M | 124.63M | 49.1M | 44.84M | 20.87M | 20.2M | 18.25M | 17.33M | 17.68M | 15.21M |
| Capitated Medicare Revenue Revenue Growth | +2.00% | +1.78% | +3.12% | +153.84% | +9.51% | +114.79% | +3.36% | +10.69% | +5.30% | -2.00% | +16.20% | n/a |
| Commercial Revenue Revenue | 137.63M | 128.08M | 124.25M | 126.68M | 96.74M | 29.87M | 56.13M | 54.93M | 52.12M | 43.92M | 33.99M | 29.45M |
| Commercial Revenue Revenue Growth | +7.46% | +3.09% | -1.92% | +30.95% | +223.84% | -46.78% | +2.18% | +5.40% | +18.67% | +29.19% | +15.41% | n/a |
| Fee-For-Service And Other Medicare Revenue Revenue | 3.17M | 2.48M | 3.07M | 2.79M | 130.7M | 120.87M | n/a | n/a | n/a | n/a | n/a | n/a |
| Fee-For-Service And Other Medicare Revenue Revenue Growth | +27.78% | -19.30% | +10.06% | -97.86% | +8.13% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Medicare Revenue Revenue | 136.6M | 133.29M | 131.59M | 127.42M | 2.78M | 590K | n/a | n/a | n/a | n/a | n/a | n/a |
| Medicare Revenue Revenue Growth | +2.48% | +1.29% | +3.27% | +4483.53% | +371.19% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Membership Revenue Revenue | 26.65M | 26.11M | 25.1M | 24.23M | 99.52M | 30.46M | n/a | n/a | n/a | n/a | n/a | n/a |
| Membership Revenue Revenue Growth | +2.06% | +4.00% | +3.60% | -75.65% | +226.69% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Fee-For-Service Revenue Revenue | 44.19M | 35.8M | 35.74M | 41.51M | 23.15M | 21.49M | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Fee-For-Service Revenue Revenue Growth | +23.44% | +0.16% | -13.91% | +79.31% | +7.74% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Partnership Revenue Revenue | 66.8M | 66.17M | 63.4M | 60.94M | 58.45M | 54.55M | n/a | n/a | n/a | n/a | n/a | n/a |
| Partnership Revenue Revenue Growth | +0.95% | +4.37% | +4.05% | +4.26% | +7.15% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 135.33M | 142.46M | 115.61M | 119.5M | 112.87M | 107.45M | 87.77M | 77.03M | 47.17M | 47.97M | 48.09M | 51.02M | 42.49M | 40.24M | 35.06M | 30.69M | 39.63M |
| Selling, General, and Administrative Revenue Growth | -5.01% | +23.22% | -3.25% | +5.87% | +5.05% | +22.43% | +13.93% | +63.32% | -1.68% | -0.24% | -5.75% | +20.08% | +5.58% | +14.78% | +14.23% | -22.54% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue | 25.03M | 26.38M | 23.19M | 22.46M | 24.36M | 14.38M | 10.57M | 12.69M | 8.12M | 7.91M | 9.78M | 11.15M | 10.69M | 12.46M | 8.09M | 8.28M | 11.41M |
| Sales and Marketing Revenue Growth | -5.12% | +13.75% | +3.27% | -7.78% | +69.37% | +36.05% | -16.70% | +56.25% | +2.62% | -19.05% | -12.35% | +4.35% | -14.23% | +54.05% | -2.22% | -27.51% | n/a |